HomeTOP STORIESNovartis to buy Excellergy for up to $2B to boost allergy portfolio Novartis to buy Excellergy for up to $2B to boost allergy portfolio By rogerjudd March 27, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleHelicopter crashes into ocean off Hawaii coast, leaving multiple dead and injuredNext articlePentagon weighs sending up to 10,000 more troops to the Middle East: report latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
